Journal of Neurology Neurosurgery & Psychiatry · 2017 · 195 citations · 31 references
MedicineNeurologyNeuroscienceDementiaInflammationNeuroimmunologyAlzheimer DiseaseCognitive ImpairmentDementia With Lewy BodiesLewy Body DementiaNeurodegenerative DiseasesNeuroinflammationAlzheimer Disease DementiaAlzheimer Disease NeuroimmunologyLewy Body Dementia BiomarkersMild Cognitive Impairment ProgressionNeuroinflammation In Alzheimer DiseaseNeuroinflammatory BiomarkersProdromal Dementia DetectionSystemic Inflammation Markers
OBJECTIVES: There is growing evidence for the role of systemic inflammation in Alzheimer's disease (AD) and other neurodegenerative diseases; however the systemic inflammatory profile in dementia with Lewy bodies (DLB) has never before been investigated. This study aimed to characterise systemic inflammatory mediators in established DLB and AD, as well as in their prodromal, mild cognitive impairment (MCI) phases. METHODS: We obtained plasma samples from patients with DLB (n=37), AD (n=20), MCI with DLB profile (n=38), MCI with AD profile (n=20) and healthy control subjects (n=20). The following inflammatory biomarkers were measured using Roche cobas c702 and Meso Scale Discovery V-Plex Plus: high-sensitivity C-reactive protein, interferon-gamma, interleukin (IL)-10, IL-12p70, IL-13, IL-1beta, IL-2, IL-4, IL-6, IL-8 and tumour necrosis factor-alpha. RESULTS: We found significantly higher levels of IL-10, IL-1beta, IL-4 and IL-2 in both MCI groups (P<0.001), while there was no significant difference in inflammatory markers between dementia groups and controls. Furthermore, increased disease severity was associated with lower levels of IL-1beta, IL-2 and IL-4 (P<0.05). INTERPRETATION: We have shown for the first time that in both DLB and AD, increased peripheral inflammation occurs early at the MCI disease stages. These data support a role for inflammation early in the disease process, and have important implications for the stage of disease where trials of anti-inflammatory medication should be focused.
31
Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.8K citations · Full text
Marilyn S. Albert, Steven T. DeKosky, Dennis W. Dickson et al. · Alzheimer s & Dementia · 2011 · 10.2K citations
Marilyn S. Albert, Steven T. DeKosky, Dennis W. Dickson et al. · FOCUS The Journal of Lifelong Learning in Psychiatry · 2013 · 2.6K citations
Medicine, Neurology, Neuroscience +15
Inflammatory proteins in plasma and the risk of dementia: the rotterdam study.
Marianne J. Engelhart, Mirjam I. Geerlings, John Meijer et al. · PubMed · 2004 · 747 citations
Medicine, Immunology, Neurology +17
Peripheral cytokines profile in Parkinson’s disease
Marcella Reale, Carla Iarlori, Astrid Thomas et al. · Brain Behavior and Immunity · 2008 · 553 citations